Clinical Trial

Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI

Study acronym: GuidedRT
Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Cancer radiation treatment plans that employ lung functional avoidance methods require 3D maps that differentiate regions of healthy lung function from regions of functional compromised tissue to deliver sufficient dose to the tumor while preserving as much functioning lung as possible. Hyperpolarized xenon-129 MRI can provide maps of ventilatory function and gas exchange to the bloodstream. Improving treatment plans based on this novel imaging modality could reduce risk or severity of radiation pneumonitis and improve post-treatment quality of life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-19.
Trial Details
NCT Number NCT07355231
Lead Sponsor Xemed LLC
Collaborators: University of Pennsylvania
Conditions Carcinoma, Non-Small-Cell Lung
Enrollment 10 participants
Start Date 2026-03-01
Primary Completion 2028-02-29 (estimated)
Study Completion 2028-02-29 (estimated)
Updated on ClinicalTrials.gov 2026-01-22